Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating GS-248 for safety and efficacy in Raynaud's phenomenon associated with systemic sclerosis has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Validity and Reliability of the Turkish Version of HAnDE
This study reports on the validity and reliability of the Turkish version of the HAnDE hand assessment in individuals with systemic sclerosi…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis [Phase 2]
A Phase 2 study evaluating autologous stem cell transplantation for progressive systemic sclerosis with cardiac involvement has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: microRNAs in Systemic Scleroderma
The document notes that a clinical trial examining microRNAs in systemic sclerosis has completed. No efficacy or safety results are provided…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Online Fatigue Intervention Program for People With Scleroderma [NA]
This update notes the completion of a clinical trial evaluating an online fatigue intervention program for people with systemic sclerosis (s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: PortoSinusoidal Vascular Diseases and Systemic Sclerosis
A completed clinical trial update from University Hospital Caen investigating Porto-sinusoidal vascular disease with or without systemic scl…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Neutrophil Extracellular Traps in Systemic Sclerosis [NA]
A completed clinical study investigating neutrophil extracellular traps in patients with systemic sclerosis and systemic lupus erythematosus…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma. [NA]
A clinical trial evaluating the EmoLED Medical Device for healing digital ulcers in patients with systemic sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Exercise With Scleroderma Functional Outcomes [NA]
A completed clinical trial evaluating the effects of an exercise program on functional outcomes in patients with systemic sclerosis (sclerod…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Exparel as a Nerve Block for Severe Hand Pain [Phase 2, Phase 3]
Phase 2/3 trial of Exparel (liposomal bupivacaine) as a nerve block for severe hand pain in CREST syndrome and peripheral vascular disease w…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Brentuximab Vedotin for Systemic Sclerosis [Phase 1, Phase 2]
A clinical trial update reports completion of Phase 1/2 studies evaluating Brentuximab Vedotin for diffuse cutaneous systemic sclerosis (scl…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study evaluating injections of allogeneic mesenchymal stem cells in adults with refractory systemic sc…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating oral Temanogrel for improving digital blood flow in adults with Raynaud's Phenomenon secondary to systemic sclerosi…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Effects of FT011 in Systemic Sclerosis [Phase 2]
Phase 2 trial update on FT011 for systemic sclerosis (scleroderma) has been completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis [Phase 1, Phase 2]
A clinical trial investigating topical sodium metabisulfite for calcinosis in systemic sclerosis is listed as Phase 1/Phase 2 with unknown s…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Rituxmab Versus IL-6 in Treating ILD [Phase 2, Phase 3]
Phase 2/3 trial comparing Rituxmab to IL-6 in treating Interstitial Lung Disease and scleroderma has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Effectiveness of Tofacitinib in Systemic Sclerosis [Phase 2]
Phase 2 trial update evaluating the effectiveness of tofacitinib in systemic sclerosis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot) [Phase 2]
Phase 2 clinical trial update for mycophenolate in limited cutaneous systemic sclerosis (MINIMISE-Pilot).
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Cold Challenge With C21 in RP [Phase 2]
Phase 2 trial update on C21 for Raynaud Phenomenon and Systemic Sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update evaluating a COVID-19 vaccine booster in immunocompromised individuals with rheumatic diseases.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab [Phase 2]
Phase 2 trial investigating rituximab (anti-CD20) as a protocol-based treatment for early and severe systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) [Phase 2]
Phase 2 trial evaluating anaerobic cultivated human intestinal microbiome transplantation for systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: The Benefit of Bermekimab in Patients With Systemic Sclerosis [Phase 2]
Phase 2 trial update evaluating bermekimab for systemic sclerosis (scleroderma) has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells [Phase 1, Phase 2]
A clinical trial update investigating autologous regulatory T-cells for systemic sclerosis in Phase 1 and Phase 2, with unknown current stat…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis [Phase 2]
Phase 2 trial of belimumab for diffuse cutaneous systemic sclerosis completed with results posted.